JJournal of Pharmaceutical Innovation3/28/2026Advances in 11-HSD1 Inhibitor Development for Addressing Insulin Resistance and Beta-Cell Dysfunction in Type 2 diabetes mellitusPallavi Joshi·Abhijit Debnath·Avijit Mazumder·Bhavani PentelaRead at Journal of Pharmaceutical InnovationTagsHormonal Regulation and HypertensionEndocrinology, Diabetes and Metabolism
